169352 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
SERIALIZABLE OBJECTS AND A DATABASE THEREOF
#602SERIALIZABLE OBJECTS AND A DATABASE THEREOF
#603PIGF-1 Assay and kits and components thereof
#604Hapten compound and antibody
#605Methods to predict and prevent resistance to taxoid compounds
#606Tanaproget derivatives, metabolites, and uses thereof
#607Method for quantification of neurotoxin
#608Method and device for monitoring medication usage
#609Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry
#610Process for determining S-nitrosothiols in biological fluids
#611POSITIVE DETECTION LATERAL-FLOW APPARATUS AND METHOD FOR SMALL AND LARGE ANALYTES
#612METHOD FOR RAPID IDENTIFICATION OF PHARMACOLOGICALLY ACTIVE CHEMICAL ENTITIES ASSOCIATED WITH THE EFFICACY OF ETHNOBOTANICAL SUBSTANCES
#613Taxol immunoassay
#614Doxorubicin immunoassay
#615Doxorubicin immunoassay
#616NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
#617Optimization and individualization of medication selection and dosing
#618Methods for determining absorption of cobalamin or analogues thereof
#619Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients
#620DRUG TARGET PROTEIN AND TARGET GENE, AND SCREENING METHOD
#621Biomarker for farnesyl pathway
#622Modular point-of-care devices, systems, and uses thereof
#623Neuroactive steroid compositions and methods of use therefor
#624IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS
#625Versatile drug testing device
#626SIMULTANEOUS ASSAY FOR DETERMINING DRUGS
#627Simultaneous assay for determining drugs
#628Risk assessment for adverse drug reactions
#629Delta-9-tetrahydrocannabinol detection method
#630DETECTION AND QUANTITATION OF CALICHEAMICIN
#631Validation Process
#632Docetaxel Immunoassay
#633COMPOSITIONS AND METHODS FOR COMBINING REPORT ANTIBODIES
#634Busulfan immunoassay
#635Risk assessment for adverse drug reactions
#636METHODS FOR MODULATING A DRUG-RELATED EFFECT OR BEHAVIOR
#637Modulators of pharmacokinetic properties of therapeutics
#638Trace amine receptor 1 of the african green monkey
#639Screening system for identifying drug-drug interactions and methods of use thereof
#640Allergen dosage form
#641Allergen dosage form
#642Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#643Lipophilic dye-based fret assays for clostridal toxin activity
#644Extractant Solution for Residual Veterinary Agent in Livestock Product or Seafood
#645Enzymatic Measurement of Imatinib Mesylate
#646METHODS OF DETERMINING ACTIVE LEVELS OF DRUGS IN FLUID SAMPLES
#647Technique for accessing a database of serializable objects using field values corresponding to fields of an object marked with the same index value
#648Apparatus for Detecting Drugs in a Beverage
#649Simultaneous assay of target and target-drug binding
#650Method to detect adulterated specimens
#651Methods for diagnosing a gastrointestinal disorder in an individual
#652USE OF BNP-TYPE PEPTIDES FOR THE STRATIFICATION OF THERAPY WITH ERYTHROPOIETIC STIMULATING AGENTS
#653CHANGEABLE MACHINE READABLE ASSAYING INDICIA
#654Screening for neurotoxic amino acid associated with neurological disorders
#655Process for the Identification of New Medical Targets
#656Blood Flow Assessment of Clostridial Toxin Applications
#657Screening for neurotoxic amino acid associated with neurological disorders
#658SVCT2 transporters expressed in blood brain barrier cells
#659Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#660Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#661Hydrophobic silica particles and methods of making same
#662Test
#663Fingerprint analysis using mass spectrometry
#664Methods for determining and lowering caffeine concentration in fluids
#6655-fluoro-uracil immunoassay
#666IMMUNOASSAY FOR HIV PROTEASE INHIBITORS
#667Multiple analyte assay device
#668Determination of free fractions
#669Methods for determining the feeding habits of an animal
#670Taxol immunoassay
#671Busulfan immunoassay
#672Testing strip and dispenser
#673Methods of screening bifunctional molecules for modulated pharmacokinetic properties
#674Screening of compounds for OCT3 transporter activity
#675METHOD AND SYSTEM FOR TESTING AND CONTROLLING A CUSTODY OF A FLUID SPECIMEN
#676Method for testing specimens located at a plurality of service sites
#677Uniqueness products acquisition system
#678Identification of targeting component of herbal medicines from simplified HPLC spectrum using after flowing through immobilized receptor (AFTIR) method
#679METHODS OF DETERMINING PHARMACOKINETICS OF TARGETED THERAPIES
#680Methods of identifying active BRM expression-promoting HDAC inhibitors
#681Isotope labeled camptothecin derivatives
#682Detection of an immune response to GDF-8 modulating agents
#683Doxorubicin immunoassay
#684Phenethanolamine-derived haptens, immunogens, antibodies and conjugates
#685Docetaxel immunoassay
#686Docetaxel immunoassay
#687Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#688Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
#689Multiple analyte assay devices
#6905-Fluoro-uracil immunoassay
#6915-Fluoro-uracil immunoassay
#692Immunoassays for lamotrigine
#693Method for determining improper manipulation of urine samples using marker compounds
#694Positive detection lateral-flow apparatus and method for small and large analytes
#695Immunoassay for HIV protease inhibitors
#696Trace amine receptor 1 of the African green monkey
#697Enzymatic measurement of imatinib mesylate
#698Taxol immunoassay
#699Rapid classification of biological components
#700Busulfan immunoassay
#701Homogeneous enzyme immunoassay for oral fluid
#702Immunoassay for HIV protease inhibitors
#703Tanaproget derivatives, metabolites, and uses thereof
#704Taxol immunoassay
#705Taxol immunoassay
#706Cytoxan antibodies and immunoassay
#707Cytoxan antibodies and immunoassay
#708Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
#709Simultaneous assay of target and target-drug binding
#710VR1 receptors and uses thereof
#711Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics
#712Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#713Site selectively tagged and templated molecularly imprinted polymers for sensor applications
#714Ion channel
#715Changeable machine readable assaying indicia
#716Reagents for assays for ligands
#717Rapid classification of biological components
#718Method for the screening of αδ-1 subunit binding ligands
#719Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
#720Indinavir derivatives useful in immunoassay
#721Detecting human anti-therapeutic antibodies
#722Risk assessment for adverse drug reactions
#723System for automatically testing a fluid specimen
#724Methods for modulating a drug-related effect or behavior
#725Method and device for monitoring medication usage
#726Diagnosing sjogren's syndrome
#727Screening for neurotoxic amino acid associated with neurological disorders
#728Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith
#729Individual drug safety
#730Compact analyte testing cassette with true positive and negative analyte controls
#731Psychoactive compound associated markers and method of use thereof
#732Date rape drug detection device and method of using same
#733Self-indicating colorimetric response materials for removal and sensing of toxic chemicals and narcotics
#734Substance detection device and method
#735Optimizing mifepristone levels for cushing'S patients
#736Self-indicating colorimetric response materials for removal and sensing of toxic chemicals and narcotics
#737Sensing paper and method of sensing abused drugs
#738Method of detecting fluorescent drug markers in urine
#739Method for identifying and tracking pharmaceutical and nutritional products using nanoparticles of different sizes and shapes
#740Toilet that detects fluorescent drug markers and methods of use thereof
#741Method of measuring food dyes in bodily waste to identify and quantify drug consumption
#742Substance detection device and method
#743Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
#744Liquid sample assay device